Zdrowie i gospodarka · 29/11/2010

FDA Releases Draft Guidance for In Vitro Diagnostic Devices to Detect Clostridium difficile

The Food and Drug Administration (FDA) has made available a draft guidance document outlining its recommendations for in vitro diagnostic devices intended to detect Clostridium difficile, a type of bacteria that causes diarrhea and colitis.